Kolon Biotech, Inc. announced a placement of 162,000 common shares at an issue price of KRW 15,500 per share for gross proceeds of KRW 2,511,000,000 on January 19, 2023. The transaction will include participation from returning investor, Kolon Life Science Inc. for 162,000 shares. The method of capital increase is through shareholder allocation.

The transaction has been approved by board of directors of the company.